Description
An NMDA receptor antagonist (Ki = 43 nM for inhibition of spermine binding); blocks generalized seizures in a mouse model of epilepsy (ED50 = 0.85 mg/kg); increases horizontal locomotor activity in mice (ED50 = 2.71 mg/kg); decreases immobility time in the tail suspension and forced swim tests in a mouse model of social defeat stress at 0.1 mg/kg; inhibits AChE (Kis = 6.2 and 7.9 μM for electric eel and rat brain AChE, respectively)
Formal name: (5R,10S)-10,11-dihydro-5-methyl-5H-dibenzo[a,d]cyclohepten-5,10-imine, (2Z)-2-butenedioate
Synonyms:
Molecular weight: 337.4
CAS: 121917-57-5
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Ion Channel Modulation|Blockers||Product Type|Biochemicals|Small Molecule Inhibitors|Acetylcholine Turnover||Research Area|Neuroscience|Behavioral Neuroscience|Depression||Research Area|Neuroscience|Seizure Disorders